Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After Same-Day Dosing of Eflapegrastim in Patients With Breast-Cancer
Public ClinicalTrials.gov record NCT04187898. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Open-Label, Phase 1 Study to Evaluate Duration of Severe Neutropenia After the Same-Day, Varying Dosing Time Schedules of Eflapegrastim Administration in Patients With Breast-Cancer Receiving Docetaxel and Cyclophosphamide
Study identification
- NCT ID
- NCT04187898
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 1
- Lead sponsor
- Spectrum Pharmaceuticals, Inc
- Industry
- Enrollment
- 59 participants
Conditions and interventions
Conditions
Interventions
- Eflapegrastim Biological
- Docetaxel Drug
- Cyclophosphamide Drug
Biological · Drug
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 10, 2020
- Primary completion
- Jul 15, 2024
- Completion
- Aug 15, 2024
- Last update posted
- Sep 18, 2024
2020 – 2024
United States locations
- U.S. sites
- 8
- U.S. states
- 5
- U.S. cities
- 8
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| ACRC/ Arizona Clinical Research Center | Tucson | Arizona | 85715 | — |
| Yuma Regional Medical Center Cancer Center | Yuma | Arizona | 85364 | — |
| Pacific Cancer Medical Center | Anaheim | California | 92801 | — |
| City of Hope | Long Beach | California | 90813 | — |
| BRCR Medical Center, Inc. | Plantation | Florida | 33322 | — |
| Bond & Steele Clinic, P.A. | Winter Haven | Florida | 33881 | — |
| SCL Health Research Institute, Inc. | Billings | Montana | 59102 | — |
| Mercy Health Youngstown | Youngstown | Ohio | 44501 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT04187898, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Sep 18, 2024 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT04187898 live on ClinicalTrials.gov.